Nichols Weston 4

4 · Crinetics Pharmaceuticals, Inc. · Filed Jun 23, 2021

Insider Transaction Report

Form 4
Period: 2021-06-22
Transactions
  • Award

    Stock Option (right to buy)

    2021-06-22+17,50017,500 total
    Exercise: $20.23Exp: 2031-06-21Common Stock (17,500 underlying)
Footnotes (1)
  • [F1]The entire number of shares subject to this option become fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION